[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Izmir City Hospital\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":215},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,8,0,[8,44,69,89,115,141,168,192],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":18,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":23,"briefSummary":25,"conditions":26,"keywords":28,"overallStatus":31,"whyStopped":4,"lastUpdateSubmitDate":32,"lastUpdatePostDateStruct":33,"startDateStruct":36,"completionDateStruct":38,"leadSponsor":40,"locationsCount":43},"100629867","tecar-therapy-in-patients-with-lumbar-radiculopathy-100629867",false,"NCT07480252","Tecar Therapy in Patients With Lumbar Radiculopathy","Efficacy of Tecar Therapy Versus Conventional Physical Therapy and Sham Treatment in Patients With Lumbar Radiculopathy: A Randomized Controlled Trial","Inclusion Criteria:\n\n* Adults aged 18-65 years\n* Clinical diagnosis of unilateral L5 and\u002For S1 lumbar radiculopathy\n* Symptom duration between 6 weeks and 6 months\n* Average radicular pain intensity ≥3 on the Visual Analog Scale (VAS) during the previous month\n* Availability of lumbar MRI and\u002For EMG performed within the previous 6 months\n* Willingness to participate and ability to provide written informed consent\n\nExclusion Criteria:\n\n* Bilateral lumbar radiculopathy\n* Lumbar spinal canal stenosis confirmed by imaging or suspected clinically (e.g., neurogenic claudication)\n* Lower limb muscle strength \\\u003C4\u002F5 according to the Medical Research Council (MRC) scale\n* Use of analgesic medications other than paracetamol during the study period\n* Physical therapy treatment for low back or radicular pain within the past 3 months\n* Contraindications to physical therapy modalities or Tecar therapy\n* Previous lumbar spine surgery or interventional spinal procedures within the last 6 months\n* Pregnancy, malignancy, or systemic neurological or rheumatologic disease\n* Advanced spinal or lower extremity deformities (e.g., scoliosis \\>20°, grade 3-4 spondylolisthesis, vertebral fracture, advanced coxarthrosis)\n* Inability to complete the intervention protocol or follow-up assessments","ALL","18 Years","65 Years",{"count":20,"type":21},90,"ESTIMATED","INTERVENTIONAL",[24],"NA","Lumbar radiculopathy is a common cause of low back and leg pain, most frequently resulting from lumbar disc herniation and nerve root irritation. Conservative management, including physical therapy modalities and exercise therapy, is generally recommended as first-line treatment for patients without progressive neurological deficits. Tecar therapy (Transfer of Energy Capacitive and Resistive) is a non-invasive electrotherapeutic modality that delivers high-frequency electromagnetic energy to deep tissues and has been proposed to reduce pain, enhance microcirculation, and promote tissue recovery. However, evidence regarding its effectiveness in lumbar radiculopathy remains limited.\n\nThe aim of this randomized controlled trial is to evaluate the efficacy of Tecar therapy in patients with lumbar radiculopathy and to compare its clinical effects with conventional physical therapy and sham Tecar treatment.\n\nA total of 90 participants with unilateral L5 and\u002For S1 radiculopathy will be randomized into three groups: (1) conventional physical therapy, (2) Tecar therapy combined with standard physical therapy, and (3) sham Tecar therapy combined with standard physical therapy. All participants will receive standardized postural education and a home exercise program.\n\nThe primary outcome will be pain intensity measured by the Visual Analog Scale (VAS). Secondary outcomes will include functional disability (Oswestry Disability Index), neuropathic pain characteristics (PainDETECT questionnaire), lumbar mobility (Modified-Modified Schober Test), nerve root irritability (Straight Leg Raise test), rescue analgesic consumption, and exercise adherence. Outcomes will be assessed at baseline, post-treatment (week 2), and follow-up visits at weeks 6 and 12.",[27],"Lumbar Radiculopathy",[29,30],"lumbar radiculopathy","Capacitive and Resistive Energy Transfer","NOT_YET_RECRUITING","2026-04-13",{"date":34,"type":35},"2026-04-16","ACTUAL",{"date":37,"type":21},"2026-04-15",{"date":39,"type":21},"2028-12-15",{"name":41,"class":42},"Izmir City Hospital","OTHER_GOV",1,{"id":45,"slug":46,"hasResults":11,"nctId":47,"briefTitle":48,"officialTitle":49,"acronym":4,"eligibilityCriteria":50,"healthyVolunteers":11,"sex":16,"minAge":51,"maxAge":4,"enrollmentInfo":52,"targetDuration":4,"studyType":54,"phases":4,"briefSummary":55,"conditions":56,"keywords":4,"overallStatus":60,"whyStopped":4,"lastUpdateSubmitDate":61,"lastUpdatePostDateStruct":62,"startDateStruct":64,"completionDateStruct":66,"leadSponsor":68,"locationsCount":43},"100597333","neuropathic-characteristics-of-subacromial-pain-syndrome-100597333","NCT07057128","Neuropathic Characteristics of Subacromial Pain Syndrome","Descriptors of Neuropathic Pain and Its Association With Central Sensitization in Subacromial Pain Syndrome","Inclusion Criteria:\n\n1. Clinical diagnosis of subacromial pain syndrome (SAPS)\n2. Age ≥ 19 years\n3. Shoulder pain lasting for at least 3 months\n4. Shoulder pain intensity rated as 3 or higher on the Visual Analog Scale (VAS) in the past week\n5. Positive findings on the following clinical tests:\n\nHawkins-Kennedy test Painful arc test Infraspinatus muscle strength test\n\nExclusion Criteria:\n\n1. History of inflammatory disease involving the shoulder joint\n2. History of neurological disorders\n3. History of prior shoulder surgery\n4. Positive drop arm test\n5. Loss of passive range of motion in the shoulder joint\n6. Presence of muscle strength loss\n7. Structurally confirmed shoulder pathology based on imaging studies\n8. Full-thickness tear of the rotator cuff muscles\n9. Presence of neurodeficit in the upper extremity\n10. Diagnosis of cancer or active infection\n11. Use of medications for neuropathic pain within the past 3 months for any reason","19 Years",{"count":53,"type":21},82,"OBSERVATIONAL","This single-center observational study aims to investigate neuropathic pain descriptors and their relationship with central sensitization in patients diagnosed with subacromial pain syndrome (SAPS) who have had shoulder pain for at least 3 months. A total of 82 participants aged 19 years or older will be recruited from the Physical Medicine and Rehabilitation outpatient clinic of Izmir City Hospital. After obtaining informed consent, participants will complete validated questionnaires assessing pain severity (VAS), neuropathic pain characteristics (painDETECT), central sensitization (Central Sensitization Inventory), and shoulder function (SPADI). Range of motion will be measured using a goniometer. No imaging or invasive procedures will be performed. Using the central sensitization scale and pain detect, the presence or absence of the 7 pain descriptors will be investigated in patients with subacromial pain syndrome with or without central sensitization and neuropathic pain pattern and it will be investigated whether the contribution of hyperalgesia, one of these pain descriptors, to neuropathic pain and central sensitization in patients with subacromial pain syndrome is greater than the contribution of other pain descriptors.The results of this study are expected to provide insight into pain mechanisms and guide clinical management in patients with SAPS.",[57,58,59],"Neuropathic Pain","Central Sensitization","Subacromial Pain Syndrome","RECRUITING","2026-04-12",{"date":63,"type":35},"2026-04-14",{"date":65,"type":35},"2025-09-15",{"date":67,"type":21},"2026-06",{"name":41,"class":42},{"id":70,"slug":71,"hasResults":11,"nctId":72,"briefTitle":73,"officialTitle":74,"acronym":4,"eligibilityCriteria":75,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":18,"enrollmentInfo":76,"targetDuration":4,"studyType":54,"phases":4,"briefSummary":78,"conditions":79,"keywords":4,"overallStatus":60,"whyStopped":4,"lastUpdateSubmitDate":81,"lastUpdatePostDateStruct":82,"startDateStruct":84,"completionDateStruct":86,"leadSponsor":88,"locationsCount":43},"100628735","ultrasound-vs-auscultation-and-fiberoptic-bronchoscopy-for-double-lumen-tube-placement-100628735","NCT07465510","Ultrasound vs. Auscultation and Fiberoptic Bronchoscopy for Double-Lumen Tube Placement","Ultrasonographic Confirmation of Double-Lumen Endobronchial Tube Placement Compared With Auscultation and Fiberoptic Bronchoscopy in Thoracic Surgery: A Prospective Observational Study","Inclusion Criteria:\n\n* Age between 18 and 65 years\n* Scheduled for elective thoracic surgery\n* Planned one-lung ventilation\n* Use of double-lumen endobronchial tube\n* ASA physical status I-III\n* Written informed consent obtained\n\nExclusion Criteria:\n\n* Known airway anomalies\n* Previous lung resection surgery\n* Tracheostomy\n* Coagulopathy\n* Pleural effusion or pleural pathology that may interfere with lung ultrasound evaluation\n* Chest wall deformity\n* Emergency surgery\n* Patients who decline participation",{"count":77,"type":21},100,"One-lung ventilation is frequently required in thoracic surgery and is most commonly achieved using double-lumen endobronchial tubes (DLTs). Correct positioning of the DLT is crucial for effective lung isolation and patient safety. Fiberoptic bronchoscopy (FOB) is considered the gold standard for confirming DLT placement; however, it may not always be immediately available and requires specific expertise.\n\nLung ultrasonography is a rapid, noninvasive, and bedside imaging method increasingly used in anesthesiology and critical care. This prospective observational study aims to evaluate the diagnostic performance of lung ultrasound in confirming the correct position of double-lumen endobronchial tubes in patients undergoing thoracic surgery.\n\nThe results obtained from lung ultrasound will be compared with auscultation findings and fiberoptic bronchoscopy results. Fiberoptic bronchoscopy will be considered the reference standard. The sensitivity, specificity, positive predictive value, and negative predictive value of lung ultrasound and auscultation will be calculated.",[80],"Thoracic Surgery With One-lung Ventilation","2026-03-06",{"date":83,"type":35},"2026-03-12",{"date":85,"type":35},"2026-01-25",{"date":87,"type":21},"2026-06-15",{"name":41,"class":42},{"id":90,"slug":91,"hasResults":11,"nctId":92,"briefTitle":93,"officialTitle":94,"acronym":95,"eligibilityCriteria":96,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":97,"enrollmentInfo":98,"targetDuration":4,"studyType":22,"phases":100,"briefSummary":101,"conditions":102,"keywords":104,"overallStatus":31,"whyStopped":4,"lastUpdateSubmitDate":108,"lastUpdatePostDateStruct":109,"startDateStruct":111,"completionDateStruct":112,"leadSponsor":114,"locationsCount":43},"100625270","silac-versus-phenol-for-the-treatment-of-pilonidal-sinus-disease-a-randomized-controlled-trial-100625270","NCT07420452","Silac Versus Phenol for the Treatment of Pilonidal Sinus Disease: A Randomized Controlled Trial","Comparison of Silac and Phenol Treatments in Primary Pilonidal Sinus Disease: A Prospective Randomized Controlled Trial With 6-Month Follow-up","SILPHEN26","Inclusion Criteria:\n\n* Age between 18 and 64 years\n* Diagnosis of primary pilonidal sinus disease\n* Maximum of three sinus openings (pits)\n* History of no more than two previous abscess episodes\n* Ability to provide written informed consent\n\nExclusion Criteria:\n\n* Recurrent or previously operated pilonidal sinus disease\n* More than three sinus openings\n* More than two previous abscess episodes\n* Acute abscess requiring emergency drainage at presentation\n* Presence of significant uncontrolled comorbidities\n* Pregnancy\n* Inability to comply with follow-up","64 Years",{"count":99,"type":21},200,[24],"Pilonidal sinus disease is a common condition affecting young adults and is associated with pain, infection, and reduced quality of life. Various minimally invasive treatment options have been developed to reduce recurrence and improve recovery time. Among these methods, Silac (laser ablation) and phenol application are frequently used techniques.\n\nThe aim of this prospective randomized controlled trial is to compare the effectiveness and safety of Silac and phenol treatments in patients with primary pilonidal sinus disease. Eligible patients will be randomly assigned to receive either Silac or phenol treatment. The primary outcome of the study is recurrence rate. Secondary outcomes include postoperative pain, healing time, time to return to work, patient satisfaction, and treatment cost.\n\nPatient recruitment is planned over a 6-month period, and each participant will be followed for 6 months after treatment. The total study duration will be 12 months. The results of this study are expected to provide evidence to guide the selection of minimally invasive treatment options for primary pilonidal sinus disease.",[103],"Pilonidal Sinus Disease",[103,105,106,107],"SiLac","Phenol","Sacrococcygeal Pilonidal Sinus","2026-02-12",{"date":110,"type":35},"2026-02-19",{"date":108,"type":21},{"date":113,"type":21},"2026-12-31",{"name":41,"class":42},{"id":116,"slug":117,"hasResults":11,"nctId":118,"briefTitle":119,"officialTitle":120,"acronym":4,"eligibilityCriteria":121,"healthyVolunteers":11,"sex":122,"minAge":17,"maxAge":123,"enrollmentInfo":124,"targetDuration":4,"studyType":54,"phases":4,"briefSummary":125,"conditions":126,"keywords":129,"overallStatus":31,"whyStopped":4,"lastUpdateSubmitDate":134,"lastUpdatePostDateStruct":135,"startDateStruct":137,"completionDateStruct":138,"leadSponsor":140,"locationsCount":4},"100622024","effects-of-patients-hormone-levels-on-sedoanalgesia-100622024","NCT07378241","Effects of Patients' Hormone Levels on Sedoanalgesia","Observation of the Effect of Patients' Hormone Levels on Sedoanalgesia in Oocyte Pcik-Up: Prospective Observational Study","Inclusion Criteria:\n\n* Between 18-45 years old\n* ASA-I ASA-II patients who were sedated for oocyte pick-up between 1 June 2025 and 1 September 2025 at Izmir City Hospital\n* Patients whose hormone levels were measured in the preoperative period due to surgical indication and registered in the hospital data processing system\n\nExclusion Criteria:\n\n* Lack of patient approvel\n* Diagnosed psychiatric disorder\n* Use of drugs affecting the central nervous system\n* Presence of chronic pain syndrome\n* History of continuous analgesic use due to chronic pain\n* Hepatic and\u002For renal insufficiency\n* BMI\\>30\n* Changing the method of anaesthesia for any reason","FEMALE","45 Years",{"count":77,"type":21},"Investigastors hypothesis is that the need for anaesthetic agents is less in patients with high progesterone levels and more in patients with high estrogen levels.",[127,128],"Consumption of Anaesthetic Agents","Sedoanalgesia",[130,131,132,133],"sedoanalgesia","OPU","Progesterone","estrogen","2026-01-28",{"date":136,"type":35},"2026-01-30",{"date":136,"type":21},{"date":139,"type":21},"2026-04-30",{"name":41,"class":42},{"id":142,"slug":143,"hasResults":11,"nctId":144,"briefTitle":145,"officialTitle":146,"acronym":147,"eligibilityCriteria":148,"healthyVolunteers":149,"sex":122,"minAge":17,"maxAge":123,"enrollmentInfo":150,"targetDuration":4,"studyType":54,"phases":4,"briefSummary":152,"conditions":153,"keywords":157,"overallStatus":31,"whyStopped":4,"lastUpdateSubmitDate":159,"lastUpdatePostDateStruct":160,"startDateStruct":162,"completionDateStruct":164,"leadSponsor":166,"locationsCount":167},"100607561","relationship-of-dv-doppler-parameters-to-perinatal-outcomes-in-iugr-vs-non-iugr-100607561","NCT07190157","Relationship of DV Doppler Parameters to Perinatal Outcomes in IUGR vs Non-IUGR","Evaluation of the Relationship Between Ductus Venosus Doppler Parameters and Perinatal Outcomes in Pregnancies With and Without Intrauterine Growth Restriction","DV-FGR","Inclusion Criteria:\n\n* Singleton pregnancies between 24 and 37 weeks of gestation Singleton pregnancies with abdominal circumference (AC) and\u002For estimated fetal weight (EFW) below the 10th percentile for gestational age Singleton pregnancies with abdominal circumference (AC) and\u002For estimated fetal weight (EFW) between the 10th and 90th percentiles for gestational age\n\nExclusion Criteria:\n\nMultiple pregnancies Pregnancies with major fetal structural anomalies or chromosomal abnormalities Pregnant women with maternal systemic comorbidities (e.g., diabetes mellitus, chronic hypertension, renal disease, autoimmune disorders) Pregnancies in women under 18 years of age Presence of perinatal infection Pregnancies conceived by in vitro fertilization (IVF)\n\n\\-",true,{"count":151,"type":21},160,"This observational study investigates whether blood flow in the ductus venosus, a small fetal vein measured by Doppler ultrasound, is related to pregnancy outcomes. A total of pregnant women with and without intrauterine growth restriction (IUGR) will be examined between 24 and 37 weeks of gestation. Ductus venosus Doppler parameters will be recorded and compared with perinatal outcomes such as Apgar scores, neonatal intensive care unit admission, and perinatal mortality. The aim of this research is to improve the early identification of high-risk pregnancies and to support better monitoring and management strategies for fetal health.",[154,155,156],"Fetal Growth Restriction","Perinatal Outcome","Pregnancy, High Risk",[155,154,158],"Pregnancy","2025-09-30",{"date":161,"type":35},"2025-10-02",{"date":163,"type":21},"2025-10-01",{"date":165,"type":21},"2025-11-30",{"name":41,"class":42},2,{"id":169,"slug":170,"hasResults":11,"nctId":171,"briefTitle":172,"officialTitle":173,"acronym":4,"eligibilityCriteria":174,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":175,"targetDuration":4,"studyType":54,"phases":4,"briefSummary":177,"conditions":178,"keywords":180,"overallStatus":31,"whyStopped":4,"lastUpdateSubmitDate":184,"lastUpdatePostDateStruct":185,"startDateStruct":187,"completionDateStruct":189,"leadSponsor":191,"locationsCount":43},"100592830","hemodynamic-effects-of-alpha-blockers-in-patients-with-spinal-anesthesia-100592830","NCT06998537","Hemodynamic Effects of Alpha Blockers in Patients With Spinal Anesthesia","The Effect of Spinal Anaesthesia on Haemodynamic Parameters in Patients Receiving Alpha Blockers","Inclusion Criteria:\n\n* Patients with American Society of Anesthesiologists (ASA) physical status classification I,II or III over 18 years of age scheduled for elective urologic surgery under spinal anesthesia\n\nExclusion Criteria:\n\n* Patients not undergoing spinal anesthesia, non-alpha-blocker vasoactive drug users, patients with cardiac disease, medical\u002Fsurgical history of brain or spinal cord, neurological or psychiatric disease",{"count":176,"type":21},80,"There is frequent use of alpha blockers in elderly patients with urological disorders. Various side effects are encountered due to the use of alpha blockers in the elderly age group. Especially hypotension is one of the common side effects. In addition, urological surgery is frequently performed in this age group. Spinal anesthesia is the most preferred anesthesia method in urological surgery. Spinal anesthesia may cause significant vasodilatation and thus hemodynamic changes such as hypotension by causing sympathetic nerve blockade. It is predicted that spinal anesthesia may increase these effects especially in individuals using α-1 adrenergic blockers. In the literature, serious hypotension has been encountered in individuals using alpha blockers under general anesthesia. The aim of this study was to compare the intraoperative hemodynamic changes in patients undergoing elective urologic surgery under spinal anesthesia between α-1 adrenergic blocker users (Group 1) and non-users(Group 2). Patients were divided into two groups according to drug use: Group 1: α-1 adrenergic blocker users (alfuzosin, doxazosin, terazosin,silodosin, tamsulosin), Group 2: No α-1 adrenergic blockers.",[179],"Patient Group With Alpha Blocker Use",[181,182,183],"spinal anesthesia","adrenergic α1-receptor antagonists,","Urologic Surgical Procedures","2025-08-19",{"date":186,"type":35},"2025-08-20",{"date":188,"type":21},"2025-08-30",{"date":190,"type":21},"2025-10-30",{"name":41,"class":42},{"id":193,"slug":194,"hasResults":11,"nctId":195,"briefTitle":196,"officialTitle":197,"acronym":4,"eligibilityCriteria":198,"healthyVolunteers":11,"sex":16,"minAge":199,"maxAge":200,"enrollmentInfo":201,"targetDuration":4,"studyType":54,"phases":4,"briefSummary":203,"conditions":204,"keywords":206,"overallStatus":31,"whyStopped":4,"lastUpdateSubmitDate":210,"lastUpdatePostDateStruct":211,"startDateStruct":212,"completionDateStruct":213,"leadSponsor":214,"locationsCount":43},"100597374","evaluation-of-difficult-airway-with-ultrasound-100597374","NCT07057661","Evaluation of Difficult Airway With Ultrasound","Evaluation of Difficult Airway in Adenotonsillectomy Patients With Ultrasound","Inclusion Criteria:\n\n1. ASA 1-2 patients\n2. Pediatric patients aged 3-8\n3. Those planned for elective surgery\n\nExclusion Criteria:\n\n1. Those with a history of congenital anomalies (head, face, body)\n2. ASA 3-4-5 patients\n3. Those who will undergo emergency surgery\n4. Those who will be subjected to an airway or anesthesia technique other than orotracheal intubation\n5. Newborn group patients\n6. Patients younger than 3 years old and older than 8 years old","3 Years","8 Years",{"count":202,"type":21},150,"An unexpected difficult airway can lead to severe hypoxia and even death. Accurate airway assessment can reduce the incidence of difficult endotracheal intubation and related complications. Studies have shown that some ultrasonic indicators can predict difficult airways in adults to some extent. Studies have begun to investigate whether ultrasonic parameters can be used to predict difficult airways in children.Ultrasonic measurements of certain airway parameters have predictive value for difficult airways; therefore, airway ultrasonography is recommended as an aid in difficult airway prediction. We think that in pediatric patients with adenotonsillectomy, we will encounter more difficult airway because there may be anatomical differentiation due to adenoid and tonsillar hypertrophy. We aimed to evaluate the frequency of difficult airway with USG measurements in pediatric patients undergoing adenotonsillectomy.\n\nGroup 1:Pediatric patients who underwent adenotonsillectomy Group 2: Pediatric patients who underwent any surgical operation We will evaluate two patient groups.",[205],"Adenotonsillectomy Surgery",[207,208,209],"airway management","pediatric patients","ultrasonography","2025-08-18",{"date":186,"type":35},{"date":188,"type":21},{"date":165,"type":21},{"name":41,"class":42},""]